相关实验视频
Updated: Jun 29, 2025

10:43
Evaluating In Vitro DNA Damage Using Comet Assay
Published on: October 11, 2017
37.6K
癌症患者的Veliparib诱导毒性:系统性审查和元分析
Peirong Wang1, Ruizhen Zhao1, Xiaohui Jin2
1Internal Medicine of Traditional Chinese Medicine, Chinese Traditional Medicine Hospital of Meishan, China.
Cancer investigation
|April 8, 2024
概括
在癌症患者中,Veliparib增加了贫血,中性质衰竭和恶心的风险. 特定的患者群体,如胃肠道瘤患者或一线治疗患者,面临更高的毒性风险.
科学领域:
- 在瘤学瘤学.
- 临床药理学 临床药理学
背景情况:
- 维利帕里布是一种用于癌症治疗的PARP抑制剂.
- 了解其毒性概况对于患者安全和治疗优化至关重要.
研究的目的:
- 在癌症患者中系统评估韦利巴里布的毒性概况.
- 为了确定特定的患者群体和治疗设置与增加的veliparib毒性相关.
主要方法:
- 一个系统的审查和随机对照试验 (RCTs) 的元分析涉及veliparib治疗.
- 分析报告的不良事件,重点关注血液和胃肠道毒性.
主要成果:
- 维利帕里布显著增加了血液毒性 (贫血,中性质衰竭,血小板衰竭) 和胃肠毒性 (恶心) 的风险.
- 在患有胃肠道瘤的患者中,更高度的中性质减退风险较高.
- 第一线治疗和较高的韦利巴里布剂量与贫血和中性质衰竭的风险增加有关.
结论:
- 维利帕里布需要仔细监测血液学和胃肠道副作用.
- 基于瘤类型,治疗线和剂量的风险分层对于管理维利巴里布毒性很重要.
相关概念视频
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
160
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
160

